Skip to main content

Table 5 Basic results. LY and QALY of the options compared

From: Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist

 

Life years

Quality-adjusted life years

Years since initiation

PSM and Dabi

PCpc and Hpc and Hvp

PSM and Dabi

PCpc and Hpc and Hvp

1

0.90

0.88

0.56

0.54

5

3.77

3.55

2.21

2.06

10

6.09

5.51

3.43

3.10

Lifetime

8.45

7.29

4.59

3.99

  1. PSM Patient self-management; PCpc Primary care with portable coagulometer; Hpc Hospital care with portable coagulometer; Hvp Hospital care with venipuncture; Dabi Dabigatran